Wuxi AppTec Co (SHSE:603259) Net Income From Continuing Operations : ¥11,324 Mil (TTM As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Wuxi AppTec Co Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Wuxi AppTec Co's net income from continuing operations for the three months ended in Mar. 2025 was ¥3,715 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2025 was ¥11,324 Mil.

Wuxi AppTec Co Net Income From Continuing Operations Historical Data

The historical data trend for Wuxi AppTec Co's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuxi AppTec Co Net Income From Continuing Operations Chart

Wuxi AppTec Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Income From Continuing Operations

Get a 7-Day Free Trial

2,986.25

5,135.95

8,902.61

9,700.26

9,567.74

Wuxi AppTec Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Income From Continuing Operations	Get a 7-Day Free Trial															1,958.85	2,321.99	2,320.77	2,966.13	3,715.47

Wuxi AppTec Co Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥11,324 Mil.

Wuxi AppTec Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Wuxi AppTec Co Ltd (SHSE:603259) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

WUXIF:USA WUXAY:USA 02359:Hong Kong WX8:Germany WX8:Germany

Address

288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai, CHN, 200131

Website

https://www.wuxiapptec.com

Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by China, Europe, and other regions.

Executives

Chen Shu Hui	senior management
Yang	Director
Hu Zheng Guo	Director
	senior management
Yao Chi	Director
Chen Min	Director
Zhu Bi Xin	senior management
Yang	senior management
Chen Shu Hui	senior management
Hu Zheng Guo	Director

Wuxi AppTec Co Headlines

No Headlines